Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P-value interpretation and alpha allocation in clinical trials

L A Moyé1

  • 1Department of Biometry, University of Texas School of Public Health, Houston 77030, USA.

Annals of Epidemiology
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A scoring system for ascertainment of incident stroke; the Risk Index Score (RISc).

Methods of information in medicine·2006
Same author

Ischemic stroke subtypes among Mexican Americans and non-Hispanic whites: the BASIC Project.

Neurology·2004
Same author

Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered.

Journal of the National Medical Association·2002
Same author

Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.

Controlled clinical trials·2001
Same author

Low-density lipoprotein size, pravastatin treatment, and coronary events.

JAMA·2001
Same author

The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.

The American journal of cardiology·2001

Clinical trial complexity complicates interpreting statistical significance. This study proposes discussing P values based on the event frequency they represent to improve clarity in complex trials.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Clinical trial complexity, including protocol deviations, multiple arms, and endpoints, complicates the interpretation of type I error rates (alpha).
  • P values and statistical power are often difficult to interpret accurately in the context of complex experimental designs.

Purpose of the Study:

  • To reformulate the discussion of P values and statistical power based on the relative frequency of the event they represent.
  • To address interpretive difficulties arising from clinical trial complexity and experimental discordance.

Main Methods:

  • Examining the link between experimental discordance (protocol deviations) and the interpretation of alpha and beta error rates.
  • Developing guidelines for allocating type I error across multiple endpoints in randomized controlled trials.

Related Experiment Videos

Main Results:

  • Experimental discordance can lead to acceptable adjustments in alpha or beta for mild deviations, but severe discordance corrupts these error rates.
  • Guidelines are proposed for allocating type I error probabilities among multiple endpoints in prospective randomized controlled trials.

Conclusions:

  • Investigators must increase sample size when including secondary endpoints to maintain acceptable type I error rates.
  • Accurate interpretation of statistical significance in complex clinical trials requires careful consideration of event probabilities and experimental execution.